Ankyra
PrivateLast Round
Series B
Nov 12, 2021
Total Funding Raised
$50M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Ankyra is a biotechnology company specializing in innovative cancer therapy services that enhance the safety and effectiveness of cytokine immunotherapies for patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ankyra Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Ankyra Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 12, 2021 | ||||
| Series A | May 4, 2020 |
Key People
Founding team and executive leadership
Ankyra Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | Series B |
| Fidelity Management & Research Company | Series B |
| Borealis Ventures | Series B |
| Polaris Partners | Series B, Series A |
| Sands Capital | Series B |
| Spring Mountain Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Clinical presentations on novel IL-12 immunotherapy at AACR 2026.
- Apr 16, 2026
Will present at the AACR 2026 conference.
Ankyra Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ankyra's valuation, stock price, and market status.